Skip to main content

27-06-2021 | Diabetes | News | Article

ADA 2021 in brief

Omnipod 5 system use reduces diabetes distress

Eleanor McDermid

medwireNews: Use of the Omnipod 5 closed-loop insulin delivery system reduces diabetes distress and improves quality of life, particularly for the carers of children with type 1 diabetes, research shows.

Presenting the findings at the virtual ADA 81st Scientific Sessions, Korey Hood (Stanford University, California, USA) commented that “parents of children with diabetes are a group in great need.”

The team looked at four psychosocial measurements. All measures improved at least slightly for the 42 teen users, their caregivers, and the caregivers of the 83 child users, but only caregivers of children had significant improvements for measures of hypoglycemia confidence, sleep quality, and general life quality.

All groups had significant improvements in diabetes emotional distress, with medium to large effect sizes on the Problem Areas In Diabetes scale, said the presenter.

Hood, who is a psychologist, stressed that “one of the main reasons for referral [to psychology services] is when people are feeling distressed. So to reduce this with the use of this system is a really significant finding.”

He added that the findings are “complementary” to the previously reported glycemic results.

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group

ADA Scientific Sessions; 25–29 June 2021

See the research in context now

with trial summaries, expert opinion and congress coverage